Document ID: chunk:federal_register_of_legislation:F2022C00921:front:0:p4
Version: federal_register_of_legislation:F2022C00921
Segment Type: other
Provision Reference: 
Character Range: 8743–11885

is defined in the Schedule 1 - Dictionary.
(11)      having chronic kidney disease before the clinical onset of peripheral artery disease;
            Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.
(12)      undergoing a course of therapeutic radiation for cancer, where the affected artery was in the field of radiation, before the clinical onset of peripheral artery disease;
(13)      having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the affected artery before the clinical onset of peripheral artery disease;
            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(14)      an inability to consume an average of at least 100 grams per day of any combination of fruit and vegetables, for at least five consecutive years within the 20 years before the clinical onset of peripheral artery disease;
(15)      having periodontitis for at least the two years before the clinical onset of peripheral artery disease;
(16)      having an autoimmune disease before the clinical onset of peripheral artery disease;
Note: Examples of autoimmune diseases include systemic lupus erythematosus, psoriasis and rheumatoid arthritis.
(17)      having a clinically significant depressive disorder for at least five years before the clinical onset of peripheral artery disease;
            Note: clinically significant is defined in the Schedule 1 - Dictionary.
(18)      taking the tyrosine kinase inhibitors nilotinib or ponatinib before the clinical onset of peripheral artery disease;
(19)      having hypertension before the clinical worsening of peripheral artery disease;
(20)      having diabetes mellitus before the clinical worsening of peripheral artery disease;
(21)      being obese for at least five years within the 20 years before the clinical worsening of peripheral artery disease;
            Note: being obese is defined in the Schedule 1 - Dictionary.
(22)      having dyslipidaemia before the clinical worsening of peripheral artery disease;
            Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.
(23)      where smoking has not permanently ceased, having smoked at least one pack-year of tobacco products before the clinical worsening of peripheral artery disease;
            Note: one pack-year is defined in the Schedule 1 - Dictionary.
(24)      where smoking has permanently ceased before the clinical worsening of peripheral artery disease:
(a)          having smoked at least five pack-years of tobacco products; or
(b)          having smoked at least one pack-year but less than five pack-years of tobacco products, and the clinical worsening of peripheral artery disease has occurred within 20 years of smoking cessation;
             Note: one pack-year is defined in the Schedule 1 - Dictionary.
(25)      where exposure to second-hand smoke has not permanently ceased, being exposed to second-hand smoke for at least 1,000 hours before the clinical worsening of peripheral artery disease;
            Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(26)      where